{"id":66246,"date":"2026-01-31T22:29:06","date_gmt":"2026-02-01T04:29:06","guid":{"rendered":"https:\/\/trimrx.com\/blog\/?p=66246"},"modified":"2026-01-31T22:29:06","modified_gmt":"2026-02-01T04:29:06","slug":"zepbound-before-and-after-what-results-to-expect","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/zepbound-before-and-after-what-results-to-expect\/","title":{"rendered":"Zepbound Before and After: What Results to Expect"},"content":{"rendered":"<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Zepbound (tirzepatide) produces some of the most dramatic before and after transformations of any weight loss medication available.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\">Clinical trial data<\/a> from the SURMOUNT-1 study shows that participants on the highest dose lost an average of 20.9% of their body weight over 72 weeks, with 91% achieving at least 5% weight loss and over half losing 20% or more.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">For someone starting at 230 pounds, that translates to losing roughly 48 pounds by the end of treatment. These results explain why Zepbound has generated so much attention since its approval for weight management in November 2023.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What the Clinical Data Shows<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The SURMOUNT-1 trial enrolled over 2,500 adults with obesity or overweight and tracked their progress on tirzepatide for 72 weeks. Results varied by dose:<\/p>\n<div class=\"overflow-x-auto w-full px-2 mb-6\">\n<table class=\"min-w-full border-collapse text-sm leading-[1.7] whitespace-normal\">\n<thead class=\"text-left\">\n<tr>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Dose<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Average Weight Loss<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Achieved 5%+<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Achieved 20%+<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">5 mg<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">16.0%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">89%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">32%<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">10 mg<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">21.4%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">96%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">52%<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">15 mg<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">22.5%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">91%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">57%<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">Placebo<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">3.1%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">35%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">These numbers represent meaningful, life-changing transformations for most participants. The 15 mg dose produced weight reductions roughly seven times greater than placebo.<\/p>\n<p><iframe class=\"sb-iframe\" style=\"width: 100%; height: auto; aspect-ratio: 16\/9;\" src=\"https:\/\/www.youtube.com\/embed\/c2YpXL3sosM\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What 20% Weight Loss Actually Looks Like<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Before and after photos can be misleading without context. Here&#8217;s what average Zepbound results translate to at different starting weights:<\/p>\n<div class=\"overflow-x-auto w-full px-2 mb-6\">\n<table class=\"min-w-full border-collapse text-sm leading-[1.7] whitespace-normal\">\n<thead class=\"text-left\">\n<tr>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Starting Weight<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">20% Loss<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Final Weight<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">180 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">36 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">144 lbs<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">200 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">40 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">160 lbs<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">220 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">44 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">176 lbs<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">250 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">50 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">200 lbs<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">280 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">56 lbs<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">224 lbs<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Losing 40 to 50 pounds typically means dropping 3 to 5 clothing sizes, dramatic changes in face and body shape, and substantial improvements in mobility and daily function.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">The Transformation Timeline<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Understanding when changes happen helps set realistic expectations.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Weeks 1 to 4 (2.5 mg):<\/strong> The starter dose focuses on tolerability. Most people notice appetite changes but minimal scale movement. Weight loss typically reaches 1% to 2%.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Weeks 5 to 8 (5 mg):<\/strong> Weight loss becomes more noticeable. Most people hit 3% to 4% by the end of month two.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Weeks 9 to 12 (7.5 mg):<\/strong> Momentum builds significantly. A <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12326891\/\">post hoc analysis<\/a> found that 82% of participants achieved at least 5% weight loss by week 12. These &#8220;early responders&#8221; went on to lose an average of 22.5% by week 72.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Weeks 13 to 16 (10 mg):<\/strong> Results accelerate further. Most people reach 8% to 10% during this window.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Weeks 17 to 20 (12.5 mg):<\/strong> Approaching the final dose escalation. Weight loss continues at a steady pace.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Weeks 21+ (15 mg):<\/strong> The maximum maintenance dose. Weight loss continues through week 60 to 72 before reaching a plateau.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">How Zepbound Compares to Alternatives<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The SURMOUNT-5 trial directly compared Zepbound to Wegovy (semaglutide), providing clear head-to-head data:<\/p>\n<div class=\"overflow-x-auto w-full px-2 mb-6\">\n<table class=\"min-w-full border-collapse text-sm leading-[1.7] whitespace-normal\">\n<thead class=\"text-left\">\n<tr>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Medication<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Weight Loss at 72 Weeks<\/th>\n<th class=\"text-text-100 border-b-0.5 border-border-300\/60 py-2 pr-4 align-top font-bold\">Waist Reduction<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">Zepbound<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">20.2%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">7.2 inches<\/td>\n<\/tr>\n<tr>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">Wegovy<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">13.7%<\/td>\n<td class=\"border-b-0.5 border-border-300\/30 py-2 pr-4 align-top\">5.1 inches<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Zepbound produced 47% greater weight loss than Wegovy in this direct comparison. Both medications are effective, but tirzepatide consistently outperforms semaglutide in clinical trials.<\/p>\n<p><img decoding=\"async\" style=\"width: 100%; height: auto;\" src=\"https:\/\/i.postimg.cc\/QtLy2bNC\/zepbound-vs-wegovy-2.jpg\" alt=\"Zepbound vs Wegovy\" \/><\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Beyond the Scale: Other Transformation Markers<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Before and after transformations involve more than weight loss. Clinical trials documented improvements across multiple health markers:<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Waist circumference<\/strong> decreased substantially. Participants on the 15 mg dose saw an average reduction of over 7 inches, indicating significant visceral fat loss.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Blood pressure<\/strong> improved meaningfully. Many participants saw clinically relevant reductions in systolic blood pressure.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Blood sugar levels<\/strong> normalized. The SURMOUNT-2 trial in people with type 2 diabetes showed HbA1c reductions alongside weight loss.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Lipid profiles<\/strong> improved. Cholesterol and triglyceride levels often decreased.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Physical function<\/strong> got better. Participants reported improved ability to perform daily activities.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Factors That Influence Individual Results<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Not everyone achieves the average 20% weight loss. Several factors affect outcomes:<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Dose achieved<\/strong> matters significantly. People who tolerate and maintain the 15 mg dose see better results than those on lower doses.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Diabetes status<\/strong> affects outcomes. The SURMOUNT-2 trial in people with type 2 diabetes showed 14.7% weight loss on the 15 mg dose compared to 22.5% in people without diabetes in SURMOUNT-1.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Early response<\/strong> predicts long-term success. The post hoc analysis found that &#8220;late responders&#8221; who hadn&#8217;t lost 5% by week 12 still achieved 11% average weight loss by week 72 if they continued treatment.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Lifestyle factors<\/strong> remain important. All clinical trials included dietary guidance (500 calorie deficit) and exercise recommendations (150 minutes weekly).<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Treatment adherence<\/strong> is critical. Consistent weekly dosing produces the best results.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Maintaining Your Transformation<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The SURMOUNT-4 trial specifically examined what happens when people stop Zepbound after achieving results. Participants who completed a 36-week lead-in period lost an average of 20.9%, then were randomized to continue tirzepatide or switch to placebo.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">After 52 additional weeks:<\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Continued tirzepatide: Lost an additional 5.5%, reaching 25.3% total<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Switched to placebo: Regained weight, ending at 9.9% total loss<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">This means stopping medication resulted in regaining roughly half the lost weight within a year. Those who continued treatment not only maintained their results but continued losing.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The conclusion is clear: Zepbound works best as ongoing treatment rather than a short-term intervention.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Managing Side Effects<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Gastrointestinal side effects are common, especially during dose escalation. The SURMOUNT trials reported nausea, diarrhea, vomiting, and constipation as the most frequent complaints.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Nausea<\/strong> typically peaks when doses increase and subsides within one to two weeks. Eating smaller meals and avoiding fatty foods helps.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong><a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/trimrx.com\/blog\/sulfur-burps-from-ozempic-causes-and-effective-remedies\/\">Sulfur burps<\/a><\/strong> bother some users. Eating slowly and avoiding carbonated beverages can reduce this.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Constipation<\/strong> responds to adequate hydration, fiber intake, and physical activity.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Discontinuation rates in SURMOUNT-1 were 14% to 16% across dose groups, meaning most people tolerate the medication well enough to continue treatment.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Setting Realistic Expectations<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Before and after photos online often show exceptional results. While some people do lose 25% or more, the average is around 20% on the highest dose. Here&#8217;s what to realistically expect:<\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\"><strong>Minimum likely result:<\/strong> 10% to 15% weight loss (still clinically meaningful)<\/li>\n<li class=\"whitespace-normal break-words pl-2\"><strong>Average result:<\/strong> 20% to 22% weight loss<\/li>\n<li class=\"whitespace-normal break-words pl-2\"><strong>Above-average result:<\/strong> 25%+ weight loss<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Even the &#8220;minimum likely result&#8221; of 10% to 15% produces significant health benefits and visible changes.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Getting Started With Tirzepatide<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">If you&#8217;re considering Zepbound or compounded <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/trimrx.com\/product\/tirzepatide\">tirzepatide<\/a> for weight loss, <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/trimrx.com\/\">TrimRx<\/a> offers telehealth consultations to help you understand your options. Compounded tirzepatide provides the same active ingredient at more <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/trimrx.com\/blog\/ozempic-coupon-and-savings-how-to-get-the-best-price\/\">accessible prices<\/a> than brand-name Zepbound.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">You can <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/start.trimrx.com\/intake\/trimrx\/glp1\/height_weight\">take the intake quiz<\/a> to see if you qualify.<\/p>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">The Bottom Line<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Zepbound produces the most substantial before and after transformations of currently available weight loss medications, with average results of 20% weight loss over 72 weeks. More than half of participants on the highest dose lost 20% or more of their body weight.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">These transformations go beyond aesthetics, encompassing improved metabolic health, reduced disease risk, and better quality of life. While individual results vary, most people who stay on treatment achieve clinically meaningful weight loss that can be maintained with continued medication and healthy lifestyle habits.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><em>This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zepbound (tirzepatide) produces some of the most dramatic before and after transformations of any weight loss medication available. Clinical trial data from the SURMOUNT-1&#8230;<\/p>\n","protected":false},"author":7,"featured_media":66247,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[14],"tags":[],"class_list":["post-66246","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zepbound"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/66246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=66246"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/66246\/revisions"}],"predecessor-version":[{"id":66248,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/66246\/revisions\/66248"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/66247"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=66246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=66246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=66246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}